Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN104945265B offers high-yield 2-aminoindene synthesis. Reduces costs and improves supply chain reliability for global pharma manufacturers.
Novel preparation method for MER/FLT3 dual-inhibitor intermediate offering high yield and cost-effective pharmaceutical manufacturing solutions for global supply chains and procurement.
Patent CN110092746B reveals a green, high-yield route for 2-amino-5-halopyridines using 4-cyano-1-butyne, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN102070586A introduces a mild hydrazone-based route for 4-heteroatom cyclohexenyl halides. Avoids cryogenic temps, ensures >97% purity, scalable for API manufacturing.
Patent CN105566367B details a palladium-free synthesis route for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN109020872B details a novel method converting unwanted paroxetine isomers into valuable racemic intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Patent CN1070833C details a high-yield route for cyclopropylacetylene derivatives, offering cost-effective manufacturing and scalable supply chain solutions for API intermediates.
Advanced synthesis patent CN112299983B enables high-purity dicamba intermediates with optimized supply chain efficiency and cost reduction.
Patent CN101397323A details a novel chemical synthesis of hydrocortisone from 17-hydroxyl-4,9-diene intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel halogenation-fluorination route for 5-fluoro-2-hydroxyacetophenone. High yield, low waste, scalable process for beta-blocker intermediates.
Patent CN107325002A details a green silver-catalyzed decarboxylative halogenation route. This method offers cost reduction in pharma intermediate manufacturing and enhanced supply chain reliability.
Patent CN101418029A reveals a cost-effective bromination route for methylprednisolone, offering high purity and scalable API intermediate manufacturing solutions.
Patent CN112573978A reveals a high-yield sulfoxide-catalyzed halogenation method offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Novel patent method reduces cost and waste for 5-iodo-2-bromobenzyl alcohol production ensuring high purity and supply chain reliability for global buyers.
Patent CN114605308A details a scalable synthesis of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane using dihalo-acyl chloride cyclization, offering significant cost and safety advantages.
Patent CN103265428A details a novel Grignard-based route for Pemetrexed intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover the advanced chemical synthesis of epidaunorubicin intermediates via patent CN109293613B. Offers superior purity and supply stability over fermentation methods.
Novel synthesis method for 1-pyridyl-2-bromoindene offers high yield and simplified steps for cost reduction in fine chemical manufacturing supply chains.
Patent CN102391175B offers a greener two-step route for high-purity electronic chemical intermediates, reducing waste and enhancing supply chain reliability for global buyers.
Patent CN119751217B details a high-purity synthesis route for 2-cyclohexyl-5-methylphenol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.